Welcome to our dedicated page for Amn Healthcare news (Ticker: AMN), a resource for investors and traders seeking the latest updates and insights on Amn Healthcare stock.
AMN Healthcare Services, Inc. (NYSE: AMN) is a healthcare workforce company that reports regularly on its financial performance, capital structure and workforce platforms. The AMN news stream features earnings releases, strategic announcements and updates on technology and partnership initiatives that affect its Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions segments.
Investors and industry observers can find quarterly results detailing consolidated revenue, segment performance, gross margin, operating income, and non-GAAP metrics such as adjusted EBITDA and adjusted diluted EPS. These releases also discuss trends in travel nurse staffing, allied staffing, locum tenens, interim leadership, language services and vendor management systems revenue, as well as commentary from management on market conditions and workforce demand.
AMN Healthcare’s news also covers corporate finance developments, including senior notes offerings, amendments to its revolving credit facility and related debt redemption activities. These items provide insight into how the company manages its capital structure and financial flexibility.
In addition, AMN issues news about its workforce technology and partnerships, such as the sale of its Smart Square scheduling software to symplr and the related commercial partnership that links AMN’s WorkWise workforce planning, analytics and AI capabilities with external scheduling and operational tools. The company’s Physician Solutions division also publishes reports on physician and advanced practitioner recruiting incentives, including starting salary trends and demand for medical specialties.
By following AMN Healthcare news, readers can track developments in healthcare staffing demand, the evolution of its workforce technology platforms, and the company’s strategic and financial decisions. This news page aggregates these updates in one place for convenient access.
AMN Healthcare (NYSE: AMN) reported Q4 2025 revenue of $748.2M and GAAP loss of ($0.20) per share; adjusted EPS was $0.22. Full‑year revenue was $2.730B (down 8%) with a net loss of ($95.7M). Cash flow from operations totaled $269M for 2025 and the company reduced total debt by $285M. First‑quarter 2026 guidance assumes ~$600M of labor disruption revenue, driving Q1 consolidated revenue guidance of $1.225–$1.240B.
AMN Healthcare (NYSE: AMN) reported Q4 2025 revenue of $748.2 million (up 2% YoY; +18% sequential) and GAAP loss of ($0.20) per share. Adjusted EPS was $0.22 and adjusted EBITDA was $54.5 million. Full-year 2025 revenue was $2.730 billion (down 8% YoY) with adjusted EPS of $1.36. Cash flow from operations was $76 million for Q4 and $269 million for the year; total debt ended at $775 million with net leverage of 3.3x. First-quarter 2026 revenue guidance is $1.225–$1.240 billion, assuming approximately $600 million of labor disruption revenue.
AMN Healthcare (NYSE: AMN) will hold a conference call to discuss fourth quarter and full year 2025 results and provide first quarter 2026 outlook on Thursday, February 19, 2026 at 5:00 p.m. ET. The company expects to issue its earnings news release after market close at approximately 4:15 p.m. ET the same day.
A live webcast and replay will be available on AMN Healthcare’s investor relations website, and live telephone participation requires registration to receive a PIN and dial-in instructions. Contact information for investor relations is provided for additional assistance.
AMN Healthcare (NYSE: AMN) reported Q3 2025 revenue of $634.5M (down 8% YoY) and adjusted EBITDA of $57.5M (down 22% YoY). GAAP net income was $29.3M or $0.76 per diluted share; adjusted diluted EPS was $0.39 (down 36% YoY). Cash from operations was $23M and proceeds from the sale of Smart Square were $65M, enabling repayment of the revolver balance.
The company completed a $400M 6.50% senior notes issuance due 2031, amended its revolver to $450M maturing 2030, and redeemed $500M of 2027 notes. Q4 2025 guidance: consolidated revenue $715–$730M, adjusted EBITDA margin 6.8%–7.3% with assumed labor disruption revenue ~ $100M.
AMN Healthcare (NYSE: AMN) will report third quarter 2025 results and discuss fourth quarter 2025 outlook on Thursday, November 6, 2025. The company expects to issue an earnings news release after market close at approximately 4:15 p.m. ET, followed by a conference call at 5:00 p.m. ET.
A live webcast and replay will be available on AMN Healthcare’s investor relations website. Investors may join the call by telephone after registering with a valid email to receive a PIN and dial-in instructions.
AMN Healthcare (NYSE: AMN) has announced the pricing of $400.0 million senior unsecured notes due 2031 with an interest rate of 6.500% per annum. The notes will be issued at 100.0% of face value and guaranteed by the company's affiliates that guarantee its credit facilities.
The company plans to use the proceeds, along with cash on hand and borrowings under a new revolving facility, to redeem all $500.0 million of its 4.625% senior notes due 2027. The redemption is scheduled for October 22, 2025, subject to the successful completion of the 2031 Notes offering, which is expected to close on October 6, 2025.
AMN Healthcare, as the leader in healthcare total talent solutions, served nearly 15 million patients at more than 2,100 healthcare systems in 2024, including 87% of top healthcare systems nationwide.
AMN Healthcare (NYSE: AMN) has announced a private offering of $400.0 million in senior unsecured notes due 2031. The company plans to use the proceeds, along with cash on hand and credit facility borrowings, to redeem all of its outstanding $500.0 million 4.625% senior notes due 2027 and cover related fees and expenses.
The 2031 Notes will be offered exclusively to qualified institutional buyers under Rule 144A and non-U.S. persons under Regulation S. As a leading healthcare talent solutions provider, AMN Healthcare served nearly 15 million patients across more than 2,100 healthcare systems in 2024, including 87% of top healthcare systems nationwide.
AMN Healthcare (NYSE:AMN), a leading healthcare talent solutions provider, reported Q2 2025 financial results with revenue of $658.2 million, down 11% year-over-year. The company posted a GAAP net loss of ($3.02) per share, primarily due to $128 million in goodwill and intangible asset impairment charges. Adjusted EPS was $0.30, down 69% from Q2 2024.
Key highlights include strong cash flow from operations of $79 million, debt reduction of $80 million, and the sale of Smart Square for $75 million. AMN Passport app reached 300,000 users. The company's Q3 2025 guidance projects revenue between $610-625 million, representing a 9-11% year-over-year decline, with adjusted EBITDA margin of 7.7-8.2%.
O.R. Staffing Solutions, a portfolio company of Argosy Healthcare Partners, has announced significant leadership changes with the appointment of Brent Bormaster as CEO, along with Mark Smith as Executive Chairman and Jerick Henley as Director to its Board.
Bormaster brings extensive experience from his previous role as President at AHS Staffing and an 18-year tenure at AMN Healthcare (NYSE: AMN) where he served as Divisional Vice President. The new leadership team, including Smith and Henley, previously collaborated in scaling and successfully exiting American Health Staffing Group (AHSG).
ORSS specializes in providing workforce solutions for operating rooms in acute care hospitals and ambulatory surgery centers, utilizing a clinician-led, operating room-centric approach known for faster onboarding and precise matching in surgical settings.
AMN Healthcare (NYSE:AMN) has released its 32nd annual physician recruiting incentives report, revealing that the average starting salary for physicians has reached $403,000. The comprehensive study shows significant salary variations across specialties, with orthopedic surgeons commanding the highest starting salary at $576,000, while pediatricians receive the lowest at $258,000.
The report highlights substantial year-over-year salary increases, with otolaryngologists seeing the largest gain of 36% to $487,000. Nurse practitioners are also experiencing rising compensation, with average starting salaries increasing 9.6% to $180,000. Additionally, physicians receive an average signing bonus of $38,315, relocation allowance of $12,619, and CME allowance of $4,073.